BioCentury
ARTICLE | Emerging Company Profile

Against radical pain

How CerSci’s non-opioids could treat acute pain and prevent chronic pain

January 5, 2018 10:50 PM UTC

CerSci Therapeutics thinks that by neutralizing peroxynitrite and other free radicals it can treat acute pain and prevent it from becoming chronic, without the potential for abuse and addiction.

CerSci was founded in 2014 to create non-opioid pain drugs, and acquired its lead candidate, CT-044, two years later from Galleon Pharmaceuticals Inc. CerSci co-founder and CSO Scott Dax was previously chief technology officer at Galleon...

BCIQ Company Profiles

CerSci Therapeutics Inc.